Compare Cardinal Health Inc (CAH) vs Global X Lithium & Battery Tech ETF (LIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Global X Lithium & Battery Tech ETF — how do they compare? Cardinal Health Inc trades at $228.57 (market cap $53.89B), while Global X Lithium & Battery Tech ETF trades at $70.79. The key difference: Cardinal Health Inc pays a 0.89% dividend while Global X Lithium & Battery Tech ETF pays none, and Cardinal Health Inc is trading nearer its 52-week high, Global X Lithium & Battery Tech ETF nearer its low. Which is the better fit depends on your goals.
| CAH | LIT | |
|---|---|---|
Market Cap | $53.89B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $239.71 | $91.62 |
52-Week Low | $146.04 | $39.73 |
Enterprise Value | $58.87B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
LIT trades at $70.24, down 2.88% today amid bearish technical signals, with moving averages indicating selling pressure. The stock has doubled over the past year, driven by strong EV and semiconductor demand. Recent news highlights global EV sales growth, particularly in Europe and China, supporting the lithium and battery technology sector. A dividend of $0.32 is scheduled for July 2026.
Outlook remains positive due to structural demand for lithium in energy storage and EVs, though risks include Chinese export controls and U.S. regulatory uncertainty. Analyst sentiment is mixed, with some highlighting momentum catalysts while technical indicators suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Global X Lithium & Battery Tech ETF
LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →
